24 results on '"Ma, Daoxin"'
Search Results
2. Analysis of gene mutation characteristics and its correlation with prognosis in patients with myelodysplastic syndromes
- Author
-
Yang, Xinyu, zhao, Hongyu, Wu, Hanyang, Guo, Xiaodong, Jia, Hexiao, Liu, Wancheng, Wei, Yihong, Can, Can, and Ma, Daoxin
- Published
- 2024
- Full Text
- View/download PDF
3. Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS/p38 MAPK/DGAT1 pathway and inhibiting M2 macrophage polarization
- Author
-
Liu, Jinting, Wei, Yihong, Jia, Wenbo, Can, Can, Wang, Ruiqing, Yang, Xinyu, Gu, Chaoyang, Liu, Fabao, Ji, Chunyan, and Ma, Daoxin
- Published
- 2022
- Full Text
- View/download PDF
4. The imbalance of Th17/Treg in patients with uterine cervical cancer
- Author
-
Zhang, Yan, Ma, Daoxin, Zhang, Yong, Tian, Yongju, Wang, Xuping, Qiao, Yunbo, and Cui, Baoxia
- Published
- 2011
- Full Text
- View/download PDF
5. Paclitaxel–octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice
- Author
-
Shen, Hongchang, Hu, Dongyan, Du, Jiajun, Wang, Xiuwen, Liu, Yanguo, Wang, Yawei, Wei, Jun-min, Ma, Daoxin, Wang, Pu, and Li, Lei
- Published
- 2008
- Full Text
- View/download PDF
6. Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia.
- Author
-
Yu, Shuang, Liu, Chuanfang, Li, Lanhua, Tian, Tian, Wang, Min, Hu, Yu, Yuan, Cunzhong, Zhang, Lei, Ji, Chunyan, and Ma, Daoxin
- Published
- 2015
- Full Text
- View/download PDF
7. Treg cells in different forms of uterine cancer
- Author
-
Hou, Fei, Ma, Daoxin, and Cui, Baoxia
- Subjects
- *
UTERINE cancer , *T cells , *IMMUNOLOGIC diseases , *HOMEOSTASIS , *CANCER immunotherapy , *CERVICAL cancer - Abstract
Abstract: Recently, studies involving uterine cervical cancer and uterine corpus cancer have been reported from many institutes. The presence of regulatory T cells (Treg cells) in human uterine cancer is crucial for maintaining immunological homeostasis. To improve treatment strategies, I will be reviewing recent studies in the field. This work will discuss the central role that Treg cells play in the development of uterine cancer, which makes these cells a key missing component in current cancer immunotherapy. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
8. Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity.
- Author
-
Wei, Yihong, Liu, Wancheng, Wang, Ruiqing, Chen, Yuhong, Liu, Jinting, Guo, Xiaodong, Can, Can, Yang, Xinyu, Wang, Dongmei, Hu, Xiang, and Ma, Daoxin
- Subjects
- *
PROPIONATES , *SHORT-chain fatty acids , *ACUTE myeloid leukemia , *HOMEOSTASIS , *IMMUNOREGULATION , *REACTIVE oxygen species - Abstract
Short-chain fatty acids (SCFAs), particularly propionate and butyrate, have been reported in many cancers. However, the relationship between propionate and acute myeloid leukemia (AML) remains unclear. Additionally, Acyl-CoA synthetase long chain family member 4 (ACSL4) has been reported to regulate immunity in solid tumors, but there are still many gaps to be filled in AML. Here, we discovered the underlying mechanism of propionate and ACSL4-mediated ferroptosis for immunotherapy. Our results showed that the level of propionate in the AML patients' feces was decreased, which was correlated to gut microbiota dysbiosis. Moreover, we demonstrated that propionate suppressed AML progression both in vivo and in vitro. In mechanism, propionate induced AML cells apoptosis and ferroptosis. The imbalance of reactive oxygen species (ROS) and redox homeostasis induced by propionate caused mitochondrial fission and mitophagy, which enhanced ferroptosis and apoptosis. Furthermore, ACSL4-mediated ferroptosis caused by propionate increased the immunogenicity of AML cells, induced the release of damage-associated molecular patterns (DAMPs), and promoted the maturation of dendritic cells (DCs). The increased level of immunogenicity due to ferroptosis enable propionate-based whole-cell vaccines to activate immunity, thus further facilitating effective killing of AML cells. Collectively, our study uncovers a crucial role for propionate suppresses AML progression by inducing ferroptosis and the potential mechanisms of ACSL4-mediated ferroptosis in the regulation of AML immunity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Distribution of Th17 cells and Foxp3-expressing T cells in tumor-infiltrating lymphocytes in patients with uterine cervical cancer
- Author
-
Hou, Fei, Li, Zhen, Ma, Daoxin, Zhang, Wenjing, Zhang, Youzhong, Zhang, Tingguo, Kong, Beihua, and Cui, Baoxia
- Subjects
- *
T helper cells , *GENE expression , *CERVICAL cancer patients , *CANCER invasiveness , *LYMPHOCYTES , *CERVICAL intraepithelial neoplasia , *IMMUNOHISTOCHEMISTRY - Abstract
Abstract: Background: Recent studies suggest a potential impact of Th17 cells on tumor. In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues. Methods: Th17 cells and Foxp3-expressing T cells were evaluated by immunohistochemical staining. IL-6, TGF-β, IL-17 and IL-10 were detected by enzyme-linked immunosorbent assay (ELISA). Immunohistochemical staining for microvessel density (MVD) was performed in order to assess the association of IL-17 expression with angiogenesis. Results: Compared with controls, patients with UCC or CIN had a higher proportion of Th17 cells and Foxp3-expressing T cells, when the ratio of Th17/Foxp3-expressing T cells in TILs was decreased in individual cases, it was more markedly decreased in TILs than normal cervical tissues. Meanwhile, the cytokine(IL-6, TGF-β and IL-10) concentrations were significantly higher in UCC patients than those in healthy controls. Interestingly, the levels of intratumoral Th17 cells were positively correlated with MVD in tumors. Conclusions: The imbalance of Th17/Foxp3-expressing T cells may play critical roles in the development and progression of UCC and Th17 cells may promote tumor progression by fostering angiogenesis. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
10. Dopamine promotes the progression of AML via activating NLRP3 inflammasome and IL-1β.
- Author
-
Wang, Hong, Zhang, Chen, Liu, Jinting, Yang, Xinyu, Han, Fengjiao, Wang, Ruiqing, Zhao, Hongyu, Hou, Ming, and Ma, Daoxin
- Subjects
- *
NLRP3 protein , *INFLAMMASOMES , *DOPAMINE , *GENE expression , *ACUTE myeloid leukemia - Abstract
Mental stress has been shown to activate sympathetic adrenergic system to produce dopamine and finally promote the progression of cancer. Dopamine can also regulate the immune system through secreting kinds of cytokines. However, what role does dopamine play in acute myeloid leukemia (AML) remains unclear. Here, we investigated the effects and mechanisms of dopamine in NLRP3 inflammasome activation and cellular viability of acute myeloid leukemia U937 cells. Our results showed that dopamine enhanced the viability of U937 cells and activated the NLRP3 inflammasome in U937 cells. To further explore the mechanism of dopamine on U937 cells, we examined the expression level of dopamine receptors (DRs). We found that the mRNA expression level of DR5 in U937 cells was significantly higher than other dopamine receptors. Furthermore, we treated U937 cells with DR1/2/3/5 antagonist before dopamine, and it manifestly reversed the NLRP3 inflammasome activation and the viability-enhancing effect in U937 cells induced by dopamine. Anti-IL-1β antibody also could partly reversed the viability-enhancing effect by dopamine. We concluded that dopamine could enhance the viability of U937 cells through DR1/5 receptor pathway and activate NLRP3 inflammasome. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. NLRP3-activated bone marrow dendritic cells play antileukemic roles via IL-1β/Th1/IFN-γ in acute myeloid leukemia.
- Author
-
Liu, Qinqin, Hua, Mingqiang, Zhang, Chen, Wang, Ruiqing, Liu, Jinting, Yang, Xinyu, Han, Fengjiao, Hou, Ming, and Ma, Daoxin
- Subjects
- *
BONE marrow cells , *ACUTE myeloid leukemia , *TH1 cells , *T cell differentiation , *T helper cells , *NLRP3 protein - Abstract
The bone marrow microenvironment of acute myeloid leukemia (AML) characterized by immunosuppressive features fosters leukemia immune escape. Elucidating the immunosuppressive mechanism and developing effective immunotherapeutic strategies are necessary. Here, we found that the Th1% and IFN-γ level were downregulated in bone marrow of AML and NLRP3-activated BMDCs promoted CD4+ T cell differentiation into Th1 cells via IL-1β secretion. However, IFN-γ-producing Th1 cells were not induced by NLRP3-activated BMDCs in the presence of the NLRP3 inflammasome inhibitor MCC950 or anti-IL-1β antibody in vitro unless exogenous IL-1β was replenished. This inhibitory effect on Th1 differentiation was also observed in Nlrp3-/- mice or anti-IL-1β antibody-treated mice. Notably, elevated Th1 cell levels promoted apoptosis and inhibited proliferation in leukemia cells via IFN-γ secretion in vitro and in vivo. Thus, NLRP3-activated BMDCs promote the proliferation of IFN-γ-producing Th1 cells with antileukemic effects and may provide insight into the basis for leukemia immunotherapy in patients with AML. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma.
- Author
-
Lu, Fei, Zhao, Yanan, Pang, Yihua, Ji, Min, Sun, Yanping, Wang, Hongchun, Zou, Jie, Wang, Yan, Li, Guosheng, Sun, Tao, Li, Jingxin, Ma, Daoxin, Ye, Jingjing, and Ji, Chunyan
- Subjects
- *
PROGRAMMED death-ligand 1 , *IMMUNOSUPPRESSION , *SUPPRESSOR cells , *CYTOTOXIC T cells , *PROGNOSIS - Abstract
The NLRP3 inflammasome plays a pro-tumorigenic role in various malignancies. However, its potential role in lymphomagenesis remains unclear. In this study, we identified an immunosuppressive state in patients with diffuse large B cell lymphoma (DLBCL), which was characterized by markedly elevated interleukin (IL)-18 levels in lymphoma tissues and positive correlation with programmed death ligand 1 (PD-L1) expression. Furthermore, NLRP3 inflammasome activation in DLBCL cell lines upregulated PD-L1 and reduced the proportion of cytotoxic T cells. NLRP3 inflammasome blockade in vivo suppressed lymphoma growth and ameliorated anti-tumor immunity by downregulating PD-L1 in the tumor microenvironment and decreasing the proportion of PD-1/TIM-3-expressing T cells, myeloid-derived suppressor cells, tumor-associated macrophages, and regulatory T cells. Further in vivo studies revealed IL-18 as the main effector cytokine involved in the negative regulation of anti-lymphoma immunity. Interestingly, NLRP3 blockers combined with anti-PD-L1 treatment exerted antagonistic effects during lymphoma therapy. Altogether, our findings indicate that NLRP3 inflammasome promotes immunosuppression by modulating PD-L1 and immune cells. Accordingly, this study highlights the prognostic and therapeutic values of the NLRP3 inflammasome in lymphoma. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Genetic polymorphisms and expression of NLRP3 inflammasome-related genes are associated with Philadelphia chromosome-negative myeloproliferative neoplasms.
- Author
-
Zhou, Ying, Yan, Shuxin, Liu, Na, He, Na, Zhang, Amin, Meng, Sibo, Ji, Chunyan, Ma, Daoxin, and Ye, Jingjing
- Subjects
- *
GENETIC polymorphisms , *MYELOFIBROSIS , *LEUKOCYTE count , *POLYCYTHEMIA vera , *BONE marrow cells , *CANCER - Abstract
Inflammation plays a crucial role in the initiation, progression and prognosis of Philadelphia chromosome-negative myeloproliferative neoplasms (MPN), which could be clinically subdivided into polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Nucleotide binding domain (NOD)-like receptor protein 3 (NLRP3) inflammasomes affect inflammatory diseases and carcinomas by excessive production of cytokines. To investigate a possible association of NLRP3 inflammasome signaling with MPN, we investigated the expression of selected inflammasome-related genes from bone marrow cells of 67 MPN patients as well as gene polymorphisms in NLRP3 (rs35829419), NF-κB1 (rs28362491), CARD8 (rs2043211), IL-1β (rs16944), and IL-18 (rs1946518). It showed that inflammasome-related genes (NLRP3, NF-κB1, CARD8, IL-1β, and IL-18) were highly expressed in BM cells from MPN patients and the increased expression was associated with JAK2V617F mutation, white blood cell counts and splenomegaly. Analysis of genetic polymorphisms in 269 MPN patients and 291 healthy controls demonstrated that NF-κB1 (rs28362491) was associated with MPN and increased expression of NF-κB1, NLRP3 and IL-1β. This research provided novel biomarkers and potential targets for MPN. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
14. The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia.
- Author
-
Zhang, Amin, Yu, Jie, Yan, Shuxin, Zhao, Xia, Chen, Chen, Zhou, Ying, Zhao, Xueyun, Hua, Mingqiang, Wang, Ruiqing, Zhang, Chen, Zhong, Chaoqin, He, Na, Ji, Chunyan, and Ma, Daoxin
- Subjects
- *
INFLAMMASOMES , *GENETIC polymorphisms , *GENE expression , *CHRONIC myeloid leukemia , *POLYMERASE chain reaction , *CYTOKINES , *PATIENTS - Abstract
NLRP3 inflammasome has been recently reported as an important risk factor in the development of cancer. But the relationship between polymorphisms of NLRP3 inflammasome related genes and chronic myeloid leukemia (CML) is rarely reported. Therefore, the aim of the present study was to investigate the association of five genetic polymorphisms (NLRP3, IL-1β, IL-18, CARD8 and NF-κB) in 267 CML patients and 344 healthy controls. We found that the AT genotype of CARD8 (rs2043211) was significantly higher compared to TT genotype in high and intermediate risk CML patients. IL-1β (rs16944) polymorphism in early molecular response at 6 months was marginally different, with more GG and less AA genotype in BCR-ABL IS >1% group. IL-18 (rs1946518) polymorphism was significantly different with more GG genotype in BCR-ABL IS >1% group at 6 months. We also demonstrated that WBC count of newly diagnosed patients carrying AG genotype was significantly higher than that of GG or AA genotype of IL-1β (rs16944). The onset age of patients carrying ins/ins genotype of NF-κB (rs28362491) was significantly older than that of ins/del and del/del genotype. Moreover, IL-1β or NLRP3 mRNA expression was decreased and IL-18 mRNA expression was increased significantly in CML patients compared with controls. In conclusion, the genetic polymorphisms of NLRP3 inflammasome may be served as potential predictors for CML. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
15. Polymorphisms of Interlukin-1β rs16944 confer susceptibility to myelodysplastic syndromes.
- Author
-
Yin, Congcong, He, Na, Li, Peng, Zhang, Chen, Yu, Jie, Hua, Mingqiang, Ji, Chunyan, and Ma, Daoxin
- Subjects
- *
MYELODYSPLASTIC syndromes , *INTERLEUKIN-1 , *GENETIC polymorphisms , *DISEASE susceptibility , *INFLAMMASOMES , *DIAGNOSIS - Abstract
Genetic factors have been shown to be associated with Myelodysplastic syndromes (MDS) susceptibility. In recent years, the role of inflammation in the promotion of tumor growth is supported by a broad range of experimental and clinical evidence. But the relationship between polymorphisms in NOD-like receptor protein 3 (NLRP3) inflammasome and MDS is rarely reported. Thus, we conducted a case-control study, and genotyped five single nucleotide polymorphisms (SNPs) (NLRP3, IL-1β, IL-18, CARD8, and NF-κB) in MDS patients and healthy controls. The association of different genotypes with patient characteristics was analyzed. Comparing MDS patients with controls, GG genotype of IL-1β (rs16944) was observed to be associated with a significantly increased risk of MDS 78/166 (48.8%) vs 26/96 (27.0%), OR = 2.1, CI (1.0–4.4). No significant association was identified regarding the rest of investigated polymorphisms and MDS susceptibility. Complex karyotypes were more frequent in patients with GG genotype of IL-1β (rs16944). Patients with IL-1β polymorphisms (rs16944) GG and GA had lower hemoglobin than those without. Patients with IL-1β polymorphisms (rs16944) GG had higher IPSS scores than those without IL-1β polymorphisms. In conclusion, our present data shows that the IL-1β polymorphisms (rs16944) GG were frequently occurred in MDS. IL-1β (rs16944) GG genotype might serve as a novel biomarker and potential targets for MDS. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
16. Decreased circulating Th22 and Th17 cells in patients with aplastic anemia.
- Author
-
Lu, Ting, Liu, Yan, Li, Peng, Yu, Shuang, Huang, Xiaoyang, Ma, Daoxin, and Ji, Chunyan
- Subjects
- *
APLASTIC anemia , *IMMUNOLOGIC diseases , *AUTOIMMUNE diseases , *MESSENGER RNA , *GENE expression , *T cells , *PATIENTS - Abstract
Background Aplastic anemia (AA) is an immune-mediated disorder and mainly related to active destruction of hematopoietic cells by effector T lymphocytes. T helper (Th) 22 cells characterized as a novel subset of CD4 + T cells participate in the pathogenesis of autoimmune and hematological diseases. However, the role of Th22 subset in AA remains unknown. Methods 31 untreated AA patients and 30 healthy controls were included in this study. The percentages of Th22, Th17 and pure Th17 cells in peripheral blood were detected by flow cytometry. ELISA to measure interleukin (IL)-22 and IL-17A plasma levels and qRT-PCR for the mRNA levels of Th22 and Th17 related molecules were performed. Results The proportions of Th22, pure Th17, Th17 cells and plasma levels of IL-22 were significantly lower in untreated AA patients than those in normal controls. A positive correlation was found between Th22 and pure Th17 cells in AA. Moreover, percentages of Th22 cells correlated positively with reticulocyte counts and percentages. In addition, STAT3/STAT5 mRNA expression ratio was elevated in AA patients. Conclusion Together, our results showed Th22 cells correlating with clinical characteristics of AA patients, indicating a possible role of Th22 immune response in the pathogenesis and therapeutic intervention of AA. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
17. DT7 peptide-modified lecithin nanoparticles co-loaded with γ-secretase inhibitor and dexamethasone efficiently inhibit T-cell acute lymphoblastic leukemia and reduce gastrointestinal toxicity.
- Author
-
Zhou, Ying, Guan, Li, Li, Wei, Jia, Ruinan, Jia, Lejiao, Zhang, Yuanyuan, Wen, Xin, Meng, Sibo, Ma, Daoxin, Zhang, Na, Ji, Min, Liu, Yongjun, and Ji, Chunyan
- Subjects
- *
LYMPHOBLASTIC leukemia , *ACUTE leukemia , *LECITHIN , *CELLULAR recognition , *T cells , *GLUCOCORTICOIDS , *RESEARCH , *DEXAMETHASONE , *RESEARCH methodology , *CELL receptors , *APOPTOSIS , *PROTEOLYTIC enzymes , *EVALUATION research , *COMPARATIVE studies , *CELL lines , *INBORN errors of metabolism , *NANOPARTICLES , *PEPTIDES , *PHARMACODYNAMICS - Abstract
T-cell acute lymphoblastic leukemia (T-ALL) is a serious hematologic malignancy and glucocorticoid resistance is the main recurrent cause for a high relapsed and death rate. Here, we proposed an effective therapeutic regimen of combining gamma-secretase inhibitors (GSIs) with dexamethasone (DEX) to overcome glucocorticoid resistance. Moreover, the bone marrow targeting DT7 peptide-modified lecithin nanoparticles co-loaded with DEX and GSI (TLnp/D&G) were developed to enhance T-ALL cells recognition and endocytosis. In vitro cytotoxicity studies showed that TLnp/D&G significantly inhibited cell survival and promoted apoptosis of T-ALL cells. Mechanically, we found that GSIs promoted DEX-induced cell apoptosis by two main synergetic mechanisms: 1) GSIs significantly upregulated glucocorticoid receptor (GR) expression in T-ALL and restored the glucocorticoid-induced pro-apoptotic response. 2) Both DEX and GSI synergistically inhibited BCL2 and suppressed the survival of T-ALL cells. Furthermore, in vivo studies demonstrated that TLnp/D&G showed high bone marrow accumulation and better antileukemic efficacy both in leukemia bearing models and in systemic Notch1-induced T-ALL models, with excellent biosafety and reduced gastrointestinal toxicity. Overall, our study provides new strategies for the treatment of T-ALL and promising bone marrow targeting systems with high transformation potential. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Development and immunological evaluation of HLA-specific chronic myeloid leukemia polyepitope vaccine in Chinese population.
- Author
-
Dong, Wenhao, Zhang, Jingru, Shao, Na, Tian, Tian, Li, Lu, Jian, Jimo, Zang, Shaolei, Ma, Daoxin, and Ji, Chunyan
- Subjects
- *
HLA histocompatibility antigens , *TREATMENT of chronic myeloid leukemia , *CANCER vaccines , *CHINESE people , *DENDRITIC cells , *CANCER immunology , *DISEASES - Abstract
Highlights: [•] We construct a novel chronic myeloid leukemia polyepitope dentritic cell (DC) vaccine (DC-BCR/ABL*WT1). [•] DC-BCR/ABL*WT1 is more specific to Chinese population. [•] DC-BCR/ABL*WT1 demonstrates strong immune response to BCR/ABL(+) patients. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
19. Increased Th22 cells as well as Th17 cells in patients with adult T-cell acute lymphoblastic leukemia.
- Author
-
Tian, Tian, Sun, Yuanxin, Li, Meng, He, Na, Yuan, Cunzhong, Yu, Shuang, Wang, Min, Ji, Chunyan, and Ma, Daoxin
- Subjects
- *
T helper cells , *LYMPHOBLASTIC leukemia , *IMMUNOREGULATION , *CD4 antigen , *FLOW cytometry ,CANCER pathophysiology - Abstract
Abstract: Background: Immune regulation is important for the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL). Th22 cells are recently-identified CD4+ T cells that implicated in the pathogenesis of many hematological diseases, such as AML. However, the role of Th22 cells in the pathophysiology of T-ALL remains unclear. We examined the Th22, Th17 and Th1 cell frequencies in peripheral blood of T-ALL patients. Methods: We studied 24 newly-diagnosed (ND), 17 morphologic complete remission (CR) T-ALL patients and 30 healthy controls. Th subsets were examined by flow cytometry. Plasma IL-22 and IL-17 concentrations were measured by ELISA. Transcription factor RORC, T-bet and AHR mRNA expressions were examined by RT-PCR. Results: Th22, Th17 frequencies, plasma IL-22 concentration and AHR expression were significantly increased in ND or CR T-ALL patients compared with controls. Moreover, Th22 showed positive correlation with Th17 or Th1 cells in T-ALL patients. However, a significant decrease of IL-17 concentration, Th1 frequency and T-bet expression was found in ND or CR ALL patients compared with controls. Furthermore, Th17 cells showed positive correlation but Th1 cells showed negative correlation with white blood cell counts. Conclusion: The profile of Th subsets was distinct for T-ALL patients and showed some correlations with clinical index, which suggest that these Th subsets may be implicated in the pathogenesis of T-ALL and be reasonable targets for therapeutic intervention. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
20. Imatinib achieved complete cytogenetic response in a CML patient received 32-year indirubin and its derivative treatment
- Author
-
Chen, Feng, Li, Lizhen, Ma, Daoxin, Yan, Shuxin, Sun, Jianzhi, Zhang, Maohong, Ji, Chunyan, and Hou, Ming
- Published
- 2010
- Full Text
- View/download PDF
21. Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia
- Author
-
Hu, Yu, Li, Haiyan, Zhang, Lei, Shan, Baozhong, Xu, Xingfang, Li, Hong, Liu, Xinguang, Xu, Shuqian, Yu, Shuang, Ma, Daoxin, Peng, Jun, and Hou, Ming
- Subjects
- *
THROMBOCYTOPENIA , *T helper cells , *AUTOIMMUNE diseases , *TRANSCRIPTION factors , *STATISTICAL correlation , *MESSENGER RNA , *INTERLEUKINS , *PATIENTS - Abstract
Abstract: T-helper (Th) 22 and Th17 cells are implicated in the pathogenesis of autoimmune diseases. However, the role of Th22 cells in the pathophysiology of immune thrombocytopenia (ITP) remains unclear. Th22, Th17 and Th1 cells in both ITP patients and healthy controls were examined by flow cytometry. Plasma interleukin-22 (IL-22) level was measured by enzyme linked immunosorbent assay (ELISA). Signal transducers and activators of transcription 3 (STAT-3) and transcription factor RAR-related organ receptor C (RORC) messenger RNA (mRNA) expressions were examined by quantitative reverse transcription polymerase chain reaction (RT-PCR). Th22 cells, Th17 cells, Th1 cells and plasma IL-22 were significantly higher in ITP patients than in healthy controls. Moreover, Th22 cells showed a positive correlation with the levels of plasma IL-22 as well as Th17 and Th1 cells in ITP patients. Significant up-regulations of both STAT-3 and RORC transcription factors were also observed. Additionally, the percentage of Th22 cells was higher in autoantibody-negative ITP patients than in autoantibody-positive patients. Our results demonstrate a possible role of Th22 cells in ITP, and thus, the blockade of IL-22 may be a reasonable therapeutic strategy for ITP. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
22. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines
- Author
-
Guo, Dongmei, Ye, Jingjing, Dai, Jianjian, Li, Lizhen, Chen, Feng, Ma, Daoxin, and Ji, Chunyan
- Subjects
- *
LYMPHOBLASTIC leukemia , *T cells , *CELLULAR signal transduction , *GENE expression , *TARGETED drug delivery , *NOTCH genes , *GENETIC regulation , *SMALL interfering RNA , *GENETICS - Abstract
Abstract: Gain-of-function mutations in Notch-1 are common in T-cell lymphoblastic leukemia (T-ALL), making this receptor a promising target for drugs such as gamma-secretase inhibitors (GSIs). However, GSIs seem to be active in only a small fraction of T-ALL cell lines with constitutive Notch-1 activity and the downstream response of Notch signaling is only partially understood. To further investigate the molecular mechanisms underlying proliferation suppression and apoptosis and explore effective downstream target genes, we used RNA interference (RNAi) technology to down-regulate the expression of Notch-1 in GSIs-resistant T-ALL cell lines. Results showed that down-regulation of Notch-1 by transfection of a small interfering RNA (siRNA) could cause SupT1 cells proliferation inhibition by inducing G0/G1 cell cycle arrest and apoptosis. The proliferation inhibitory and apoptotic effects resulting from down-regulation of Notch-1 may be mediated through regulating the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 and the activity of Akt signaling. In addition, our results demonstrated that down-regulation of Notch-1 signaling could sensitize SupT1 cells to adriamycin. Taken together, cell cycle regulatory proteins and Akt signaling may be attractive targets in T-ALL. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
23. Both splenic CD5+ B and CD5− B cells produce platelet glycoprotein-specific autoantibodies in chronic ITP
- Author
-
Hou, Ming, Lv, Baojun, He, Qingsi, Lu, Lu, Shi, Yan, Ji, Xuebin, Ma, Daoxin, and Zhang, Maohong
- Subjects
- *
B cells , *GLYCOPROTEINS - Abstract
The objective of the present study is to determine splenic B-cell subsets and the ability of splenic CD5+ B and CD5− B cells to produce platelet glycoprotein-specific autoantibodies in chronic idiopathic thrombocytopenic purpura (ITP). Splenic CD5+ B cells were identified by two-color flow cytometric analysis in eight ITP patients. Magnetic activated cell sorting (MACS) purified splenic CD5+ B cells and CD5− B cells were cultured separately in vitro. Glycoprotein-specific autoantibodies in culture supernatants and plasma were measured by modified monoclonal antibody immobilization of platelet antigen (MAIPA) assay. The percentage of splenic CD5+ B cells in ITP patients was slightly higher than that in controls, with no statistical significance. Four ITP patients displayed plasma IgG autoantibodies against both GPIIb/IIIa and GPIb. Moreover, splenic CD5+ B cells and CD5− B cells from these four ITP patients also produced high level of IgG anti-GPIIb/IIIa and anti-GPIb antibodies. However, we were unable to detect IgM GP-specific autoantibodies in culture supernatant and plasma in these ITP patients. It is concluded that both splenic CD5+ B cells and CD5− B cells produce platelet IgG GP-specific autoantibodies, and may all play a role in the pathogenic process of ITP. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
24. Epimedium polysaccharides attenuates hematotoxicity by reducing oxidative stress and enhancing immune function in mice model of benzene-induced bone marrow failure.
- Author
-
He, Jin, Zang, Shaolei, Liu, Na, Ji, Min, Ma, Daoxin, and Ji, Chunyan
- Subjects
- *
BONE marrow , *BONE marrow cells , *OXIDATIVE stress , *BLOOD cell count , *EPIMEDIUM - Abstract
• Benzene induces oxidative stress, apoptosis and S-phase arrest in bone marrow cells, and decreases T cell counts in mice. • Epimedium polysaccharides (EPS) attenuates BZ-induced hematotoxicity and increases blood cell counts in BMF mice. • EPS inhibits BZ-induced ROS production and increases T cell counts in BMF mice. Chronic benzene (BZ) exposure is associated with multiple adverse health effects and leads to progressive bone marrow failure (BMF). BZ-induced BMF is an acquired aplastic anemia characterized by severe anemia, neutropenia and thrombocytopenia, which is likely caused by immunotoxicity and oxidative stress. Previous studies showed that Epimedium polysaccharides (EPS), a natural and major herbal compound derived from Epimedium, has immunomodulatory and antioxidant potential. The purpose of this study was to evaluate the potential efficacy of EPS against BZ-induced BMF. BMF mouse model was established by subcutaneous injection of 2 ml/kg BZ in CD1 mice. Mice received daily oral treatment with 100 mg/kg high-dose EPS and 20 mg/kg low-dose EPS for four weeks. Our data showed that EPS treatment alleviated BZ-associated weight loss and increased the number of whole blood cells in peripheral blood and nucleated cells in bone marrow. Furthermore, EPS treatment decreased apoptotic rate and reactive oxygen species production, S-phase arrest in bone marrow cells. Finally, EPS treatment improved T cell-mediated immune suppression by increasing CD3+, CD4 + T-cell counts, and CD4+/CD8+ ratio. and modulated hematopoietic cytokines including EPO, IL-11, and IL-2 in peripheral blood. Our study suggests that EPS is a potential therapeutic target to attenuate hematotoxicity induced by BZ. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.